CLINICAL_TRIALS
trial_result
· 2012-05-25
Clinical Trial Update: BUILD 3: Bosentan Use in Interstitial Lung Disease [Phase 3]
Summary
Phase 3 trial update for bosentan use in interstitial lung disease, focusing on idiopathic pulmonary fibrosis; results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Actelion | Conditions: Idiopathic Pulmonary Fibrosis | Phase 3 | Status: COMPLETED | Results posted: 2012-05-25